CXC chemokine receptor 4 (CXCR4; NPY3R); programmed cell death 1 ligand 1 (CD274 molecule; PD-L1; B7-H1); CTLA-4 (CD152) BriefCommunication Pages: 15 - 15
Neuropeptide Y receptor Y2 (NPY2R); peptide tyrosine-tyrosine (PYY) BriefCommunication Pages: 20 - 20
Adrenergic receptor α1 (ADRA1); ADRA2; adenylate cyclase 1 (ADCY1; AC1) BriefCommunication Pages: 28 - 28
Serum factor protein microarrays to identify autoreactive antibodies in patients with autoimmune disease BriefCommunication Pages: 31 - 31
Site-selective fluorination of aryl carbons in nitrogen heterocycles BriefCommunication Pages: 32 - 32
In silico prediction of drug toxicity based on effective plasma concentration BriefCommunication Pages: 33 - 33
Dorsal root ganglion (DRG) neurons from transgenic mice expressing human microtubule-associated protein-τ (MAPT; tau; FTDP-17) P301S recapitulate tau pathology in vitro BriefCommunication Pages: 34 - 34
Differentiation of human induced pluripotent stem (iPS) cells into renal progenitor–like cells with tissue-forming potential BriefCommunication Pages: 36 - 36
Ultra-pH–sensitive (UPS), fluorescent nanoprobe–based nanoparticles for tumor imaging BriefCommunication Pages: 37 - 37
Cyclin-dependent kinase 12 (CDK12) loss-of-function mutations as predictors of poly(ADP-ribose) polymerase (PARP) inhibitor response BriefCommunication Pages: 38 - 38
Testis expressed 101 (TEX101) and extracellular matrix protein 1 (ECM1) as biomarkers to identify subtypes of infertile azoospermia patients BriefCommunication Pages: 39 - 39